apelin
apelin is a pharmaceutical drug with 6 clinical trials. Currently 1 active trials ongoing. Historical success rate of 100.0%.
Success Metrics
Based on 4 completed trials
Phase Distribution
Phase Distribution
2
Early Stage
1
Mid Stage
0
Late Stage
Highest Phase Reached
Phase 2Trial Status & Enrollment
100.0%
4 of 4 finished
0.0%
0 ended early
1
trials recruiting
6
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Effect of Apelin on Insulin Sensitivity in Type 2 Diabetic Volunteers
Investigating the Inotropic Potential of Apelin
A Series of Pilot Studies to Evaluate the haemoDynamic and mEtabolic Effects oF apelIn aNd rElaxin
Effect of Apelin on Insulin Sensitivity: Proof of Concept in Healthy Volunteers
Effects of Apelin on the Lung Circulation in Pulmonary Hypertension
Clinical Trials (6)
Effect of Apelin on Insulin Sensitivity in Type 2 Diabetic Volunteers
Investigating the Inotropic Potential of Apelin
A Series of Pilot Studies to Evaluate the haemoDynamic and mEtabolic Effects oF apelIn aNd rElaxin
Effect of Apelin on Insulin Sensitivity: Proof of Concept in Healthy Volunteers
Effects of Apelin on the Lung Circulation in Pulmonary Hypertension
Investigating Systemic and Local Vascular Responses to Apelin in the Context of Renin-angiotensin Upregulation
All 6 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 6